Back to search

University of Patras

Μελέτη της επίδρασης χορήγησης κλοπιδογρέλης σε ασθενείς με συστηματική σκλήρυνση στην παραγωγή σεροτονίνης και τις κλινικές εκδηλώσεις της νόσου

Abstract

dc:description

Objectives: Activated platelets release serotonin that binds 5-HT2B receptor on fibroblasts leading to fibroblast activation. Clopidogrel, an inhibitor of ADP-dependent platelet activation prevents fibrosis in animal models of systemic sclerosis (SSc). We aimed at assessing whether i) ADP-dependent platelet activation is increased in patients with SSc compared to healthy subjects and patients with rheumatoid arthritis (RA) and ii) whether clopidogrel can effectively suppress ADP-dependent activation, reduce circulating serotonin levels and hence, favorably affect fibrosis or vasculopathy in patients with systemic sclerosis.Methods: Thirteen patients with SSc were recruited. Platelet activation was assessed by aggregometry prior to and following 14 days of clopidogrel treatment. At the same time points serotonin, soluble vascular cell adhesion molecule 1 (s-VCAM1) and soluble intercellular cell adhesion molecule 1 (s-ICAM1), two markers of endothelial dysfunction, were measured. Results: ADP-dependent platelet activation was similar between patients with SSc (n=13), patients with RA (n=28) and healthy subjects (n=22) (mean ± SEM AU*min: 392.1 ± 58.4, 535.5 ± 61.33 and 570.9 ± 42.9 in patients with SSc, patients with RA and healthy subjects respectively, p=0.14). Clopidogrel treatment significantly reduced platelet activation in patients with SSc (mean ± SEM AU*min: 392.1 ± 58.4 vs 163.8 ± 51.7, p=0.014). Clopidogrel treatment did not affect serotonin levels but led to a significant increase in s-VCAM 1 (p=0.03). Three patients developed new digital ulcers during the study. The potential association of the study drug with the development of new digital ulcers led to early termination of the study.Conclusion: Clopidogrel may worsen markers of endothelial function and associate with development of new digital ulcers in patients with SSc.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ntelis, Konstantinos
  • Ντελής, Κωνσταντίνος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41758

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ntelis, Konstantinos; Ντελής, Κωνσταντίνος. Μελέτη της επίδρασης χορήγησης κλοπιδογρέλης σε ασθενείς με συστηματική σκλήρυνση στην παραγωγή σεροτονίνης και τις κλινικές εκδηλώσεις της νόσου. University of Patras, 2017. http://hdl.handle.net/10442/hedi/41758